Dr. Edward A. Fisher, MD, PhD, MPH, is the Leon Charney Professor of Cardiovascular Medicine at the New York University (NYU) School of Medicine. At NYU, he is also the Founding Director of the Center for the Prevention of Cardiovascular Disease, Director of the Center's Translational Research Program, and Director of the Marc and Ruti Bell Program in Vascular Biology. He is a graduate of the NYU School of Medicine and received his clinical training at Duke and Harvard. He also holds a PhD from MIT in biochemistry and nutrition and was a post-doctoral fellow at the NIH in molecular genetics. He is an active practitioner in preventive cardiology, with a particular interest in lipid disorders, and has been recognized by the National Lipid Association for "extraordinary expertise and contributions to the field of clinical lipidology." In addition, Dr. Fisher has a robust research program, which includes investigations of the cell biology of the very low density lipoproteins (the precursors of LDL), the regression of atherosclerosis, including its imaging, and the development of nanoparticles to target therapies directly to atherosclerotic plaques and other sites of inflammation. He has published over 350 peer-reviewed articles on both clinical and research topics. His expertise is further reflected by his serving on the editorial boards of the Journal of Clinical Investigation, Journal of Lipid Research, Journal of Clinical Lipidology, Circulation Research, and his service as Editor in Chief of the American Heart Association journal, Arteriosclerosis, Thrombosis, and Vascular Biology. He has a number of honors, including membership in Alpha Omega Alpha (the national honor society of American medical schools) and the American Association of Physicians, the Ruth Gray Memorial Lectureship (Evanston/Northwestern Health Care), the Solomon A. Berson Award in Basic Science Research Achievement (NYU), the Distinguished Achievement and the George Lyman Duff Memorial Lecture Awards (American Heart Association) for his contributions to the fields of atherosclerosis and lipid metabolism. In 2007, he was a Pfizer/American College of Cardiology Visiting Professor of Preventive Cardiovascular Medicine at the University of Virginia. From 2010-2011 he was the George Eastman Professor at Oxford University and a fellow of Balliol College, an honor shared with 13 Nobel laureates.